Smarter trial strategy,
powered by data intelligence
Move beyond static databases with flexible feasibility modeling, site capacity insights, and global clinical intelligence
All 44 records selected
Search
CRO
Location
Country
Taiwan
USA
Morocco
France
USA
Spain
USA
France
France
Spain
Spain
Spain
Spain
Spain
Site Tier
Disclosed Site
5
Tier 5 sites
3
Service Provided
2
Tier 2 sites
2
Tier 5 sites
Sponsors
Advance filter
NCI
56,635
48,210
73,895
73,895
John Hopkins
972
48,210
73,895
150
NIDA
1,200
55,300
90,450
180
National Insti...
675
28,670
52,590
110
Massachuset...
850
32,145
60,720
120
National He...
850
32,145
60,720
120
PHARMA
BIOTECH
Emerging Biotech
All
(any field)
Don’t contain
Enter Keyword
Food Hypersensitivity
Medication Reactions
Soy Food
State Food and Drug Administration
Non-Allergic Rhinitis
Type to Search...
2
Search
Search +
Identify countries
Dashboard
Select Indication
Trail
Phase
Properties
Trials
Drugs
Sites
Person
Publication
Presentation
Sponsor
Geography
AB
Acme biopharma
team@acmebiopharma.com
All 44 records selected
Search
CRO
Location
Country
Taiwan
USA
Morocco
France
USA
Spain
USA
France
France
Spain
Spain
Spain
Spain
Spain
Site Tier
Disclosed Site
5
Tier 5 sites
3
Service Provided
2
Tier 2 sites
2
Tier 5 sites
Sponsors
Advance filter
NCI
56,635
48,210
73,895
73,895
John Hopkins
972
48,210
73,895
150
NIDA
1,200
55,300
90,450
180
National Insti...
675
28,670
52,590
110
Massachuset...
850
32,145
60,720
120
National He...
850
32,145
60,720
120
PHARMA
BIOTECH
Emerging Biotech
All
(any field)
Don’t contain
Enter Keyword
Food Hypersensitivity
Medication Reactions
Soy Food
State Food and Drug Administration
Non-Allergic Rhinitis
Type to Search...
2
Search
Search +
Identify countries
Dashboard
Select Indication
Trail
Phase
Properties
Trials
Drugs
Sites
Person
Publication
Presentation
Sponsor
Geography
AB
Acme biopharma
team@acmebiopharma.com
PHARMA
BIOTECH
Emerging Biotech
All
Enter Keyword
Food Hypersensitivity
Medication Reactions
Soy Food
State Food and Drug Administration
Non-Allergic Rhinitis
Type to Search...
2
Search
Search +
Dashboard
Select Indication
Trail
Phase
Properties
Trials
Drugs
Sites
Person
Publication
Presentation
Sponsor
Geography
AB
Acme biopharma
team@acmebiopharma.com
What We Do
Discover the power of TA Scan
What We Do
Discover the power of TA Scan
General Info
Type
Hospital
Total trials
7788
Investigators associated to this site
Hospital
Address
Hospital
Tier site
5
4
3
2
1
Indication Coverage
5
Enrollment Median
2
Number of Sites Median
EU : 0.00 %
BRIC : 0.00 %
US : 1.82 %
Other : 98.18 %
Prioritize sites with capacity to recruit
Identify sites with proven experience, available capacity, and the right patient mix globally
Rank sites
Forecast capacity
Balance diversity
General Info
Type
Hospital
Total trials
7788
Investigators associated to this site
Hospital
Address
Hospital
Tier site
5
4
3
2
1
Indication Coverage
5
Enrollment Median
2
Number of Sites Median
EU : 0.00 %
BRIC : 0.00 %
US : 1.82 %
Other : 98.18 %
Prioritize sites with capacity to recruit
Identify sites with proven experience, available capacity, and the right patient mix globally
Rank sites
Forecast capacity
Balance diversity
Score, rank and engage experts
Combine clinical and scientific insights to identify reliable investigators with the right expertise and track record for your protocol
Find the right experts
Score profiles objectively
Map networks
Country
Taiwan
Spain
Morocco
France
USA
Sub population
Treatment line
Bio markers
HCP LEVEL DIVERSITY
Trial landscapes
FILTER SETTINGS
5
5
5
Score, rank and engage experts
Combine clinical and scientific insights to identify reliable investigators with the right expertise and track record for your protocol
Find the right experts
Score profiles objectively
Map networks
Country
Taiwan
Spain
Morocco
France
USA
Sub population
Treatment line
Bio markers
HCP LEVEL DIVERSITY
Trial landscapes
FILTER SETTINGS
5
5
5
Creutzfeldt-Jakob disease
Creutzfeldt-Jakob disease
Search +
Search +
Scores of Top investigators
Scores of Top investigators
5
5
Trial Phase
Trial Phase
2
2
Trial State
Trial State
1
1
Fee disclosure funds
Fee disclosure funds
Map the therapeutic landscape
Compare sponsor activity, overlapping sites, and trial timing to uncover whitespace opportunities and make confident, well-timed decisions
Understand competition
Avoid enrollment conflicts
Target high-potential regions
Creutzfeldt-Jakob disease
Search +
Scores of Top investigators
5
Trial Phase
2
Trial State
1
Fee disclosure funds
Map the therapeutic landscape
Compare sponsor activity, overlapping sites, and trial timing to uncover whitespace opportunities and make confident, well-timed decisions
Understand competition
Avoid enrollment conflicts
Target high-potential regions
Predict enrollment with confidence
Build realistic, data-backed feasibility plans and test multiple strategies with predictive analytics to set achievable timelines
Validate assumptions
Forecast timelines
Compare strategy options
How to access
Flexible data access for every workflow.
industries
Built for all industries and any scale of research.
industries
Built for all industries and any scale of research.
As portfolios scale, precision matters
TA Scan delivers analytics-ready clinical intelligence that helps pharma teams prioritize opportunities, strengthen feasibility, and accelerate execution
Align study design with reality
Drive operational efficiency
Track competitors and pipeline shifts
As portfolios scale, precision matters
TA Scan delivers analytics-ready clinical intelligence that helps pharma teams prioritize opportunities, strengthen feasibility, and accelerate execution
Align study design with reality
Drive operational efficiency
Track competitors and pipeline shifts
As portfolios scale, precision matters
TA Scan delivers analytics-ready clinical intelligence that helps pharma teams prioritize opportunities, strengthen feasibility, and accelerate execution
Align study design with reality
Drive operational efficiency
Track competitors and pipeline shifts
Empower lean teams with insights
TA Scan gives biotech teams access to clinical intelligence to guide strategic feasibility, de-risk site selection, and support confident partnerships.
Assess feasibility
Identify the right sites
Select partners
Empower lean teams with insights
TA Scan delivers analytics-ready clinical intelligence that helps pharma teams prioritize opportunities, strengthen feasibility, and accelerate execution
Assess feasibility
Identify the right sites
Select partners
Empower lean teams with insights
TA Scan delivers analytics-ready clinical intelligence that helps pharma teams prioritize opportunities, strengthen feasibility, and accelerate execution
Assess feasibility
Identify the right sites
Select partners
Win more studies through differentiation
TA Scan equips CRO teams with reliable clinical intelligence to support faster proposals, stronger site strategies, and differentiation in every bid response.
Ground feasibility
Identify potential risks upfront
Strengthen bid responses
Win more studies through differentiation
TA Scan delivers analytics-ready clinical intelligence that helps pharma teams prioritize opportunities, strengthen feasibility, and accelerate execution
Ground feasibility
Identify potential risks upfront
Strengthen bid responses
Win more studies through differentiation
TA Scan delivers analytics-ready clinical intelligence that helps pharma teams prioritize opportunities, strengthen feasibility, and accelerate execution
Ground feasibility
Identify potential risks upfront
Strengthen bid responses
From discovery to strategy
TA Scan supports any organization advancing clinical research — providing reliable intelligence to guide feasibility, planning, and strategic collaboration.
Understand the trial landscape
Collaborate confidently with partners
Plan with accuracy
From discovery to strategy
TA Scan delivers analytics-ready clinical intelligence that helps pharma teams prioritize opportunities, strengthen feasibility, and accelerate execution
Understand the trial landscape
Collaborate confidently with partners
Plan with accuracy
From discovery to strategy
TA Scan delivers analytics-ready clinical intelligence that helps pharma teams prioritize opportunities, strengthen feasibility, and accelerate execution
Understand the trial landscape
Collaborate confidently with partners
Plan with accuracy
Every phase of research
Every phase of research
Every phase of research
0%
0%
Real operational value
Site capacity warning has real operational value
0%
0%
More investigators identified
Expand candidate pools beyond historical lists
0+
0+
hrs
Saved per feasibility cycle
Save up to 2.5 weeks in feasibility research per study
“Because of TA Scan, we decreased the time it takes for that initial vetting of our sites, gaining an efficiency advantage in clinical operations”
Top 10 pharma company
“Because of TA Scan, we decreased the time it takes for that initial vetting of our sites, gaining an efficiency advantage in clinical operations”
Top 10 pharma company
Mae
Louis
Streamline your Feasibility
Streamline your KOL identification
Cut feasibility timelines in half
i
n
h
a
l
f
— what once took weeks now takes days
in half
i
n
h
a
l
f
Cut feasibility timelines in half
i
n
h
a
l
f
— what once took weeks now takes days
in half
i
n
h
a
l
f
2.5 weeks saved up
Teams report saving up to 2.5 weeks in feasibility research per study.
Mae
Louis
Mae
Louis
How to get started
Where people and analytics do research work together
Create your account
Sign up or request a demo through the TA Scan website.
Connect your data sources
Explore the modules
How to get started
Where people and analytics do research work together
Create your account
Sign up or request a demo through the TA Scan website.
Connect your data sources
Explore the modules
How to get started
Where people and analytics do research work together
Create your account
Sign up or request a demo through the TA Scan website.
Connect your data sources
Explore the modules
Case study
Clinical Trial Planning Doesn’t Need to Be Guesswork.
0%
0%
0K+
0K+
0K+
0K+
of sites fail to enroll patients, before you even notice.
